Patients to suffer for PBS delisting

Concern is growing among healthcare lobby groups and patients that the decision to delist some OTC medicines from the PBS from 1 January 2016 may significantly increase costs to chronically ill patients.

Removing the PBS Subsidy for certain low-cost, over-the-counter medicines was one of the cornerstones of the Federal Governments PBS sustainability package, released earlier this year.

“In general, over-the-counter medicines are inexpensive but after applying the pharmacy remuneration charges for dispensing, the cost of these products to the Government when accessed via the PBS is disproportionally